Title: Google-backed AI drug discovery startup Isomorphic Labs delays clinical trial timeline
Source: Yahoo
Date: 2026-01-21T01:24:23
---
Isomorphic Labs, which uses artificial ​intelligence for drug discovery, ‌expects to have its first ‌clinical trials by the end of 2026, founder and CEO Demis Hassabis ⁠said on ‌Tuesday.  Hassabis had said last year the company would have AI-designed drugs in clinical trials by ⁠the end of ​2025.  Isomorphic was ​founded in 2021 as a spin-off from Alphabet's ‍AI ⁠research subsidiary, Google DeepMind, which is headed by ⁠Hassabis.